Upgrade to SI Premium - Free Trial

NextCure, Inc. (NXTC) Misses Q3 EPS by 6c

November 8, 2024 6:23 AM

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

Categories

Earnings